Immunohistochemical versus molecular (BluePrint and MammaPrint) subtyping of breast carcinoma. Outcome results from the EORTC 10041/BIG 3-04 MINDACT trial.
about
An inter-observer Ki67 reproducibility study applying two different assessment methods: on behalf of the Danish Scientific Committee of Pathology, Danish breast cancer cooperative group (DBCG).Conventional Pathology Versus Gene Signatures for Assessing Luminal A and B Type Breast Cancers: Results of a Prospective Cohort Study.
P2860
Immunohistochemical versus molecular (BluePrint and MammaPrint) subtyping of breast carcinoma. Outcome results from the EORTC 10041/BIG 3-04 MINDACT trial.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Immunohistochemical versus mol ...... 10041/BIG 3-04 MINDACT trial.
@en
Immunohistochemical versus molecular
@nl
type
label
Immunohistochemical versus mol ...... 10041/BIG 3-04 MINDACT trial.
@en
Immunohistochemical versus molecular
@nl
prefLabel
Immunohistochemical versus mol ...... 10041/BIG 3-04 MINDACT trial.
@en
Immunohistochemical versus molecular
@nl
P2093
P2860
P1476
Immunohistochemical versus mol ...... C 10041/BIG 3-04 MINDACT trial
@en
P2093
E J Rutgers
F A de Snoo
J Bogaerts
K Tryfonidis
L Stork-Sloots
L van 't Veer
P2860
P2888
P304
P356
10.1007/S10549-017-4509-9
P407
P50
P577
2017-09-19T00:00:00Z
P6179
1091862164